Does Iris Color Affect Atropine?
Meta-analysis examines whether iris color influences atropine 0.01% and 0.05% efficacy in myopia
Clinical Scorecard: Does Iris Color Affect Atropine?
At a Glance
Category Detail
Condition Myopia management Key Mechanisms Atropine binding to melanin in the iris may influence therapeutic concentrations. Target Population Children aged 5–16 years with myopia Care Setting Ophthalmology clinics
Key Highlights
Low-dose atropine (0.01%) shows differing efficacy based on iris color. Children with non-brown irides experienced less myopia progression compared to placebo. No significant treatment effect observed in children with brown irides at 0.01% concentration. Atropine 0.05% showed no iris color-related differences in efficacy. Guideline-Based Recommendations
Diagnosis
Assess myopia progression in children aged 5–16 years. Management
Consider low-dose atropine for myopia management. Monitoring & Follow-up
Monitor myopia progression and treatment response. Risks
Potential for reduced efficacy of low-dose atropine in patients with darker irides. Patient & Prescribing Data
Children with myopia, particularly those with varying iris colors.
Atropine 0.01% may be less effective in patients with brown irides; consider higher concentrations if response is limited.
Clinical Best Practices
Evaluate iris color when prescribing atropine for myopia management. Related Resources & Content
